
Healthcare · BSE
Incorporated in 2014, Trident Lifeline Limited is engaged in the marketing and distribution of pharmaceutical products in domestic and international markets through a third-party distribution network. The company offers a portfolio of 832 products as of May 31, 2022, including antibiotics, antifungals, antimalarials, antidiabetics, dental care products, proton pump inhibitors, antihistamines, antihypertensives, antiparasitics, multivitamins, multiminerals, and NSAIDs. Its core business includes ethical marketing of pharmaceutical formulations internationally under its brand and sourcing approved formulations through contract manufacturers for both domestic and global markets. Trident Lifeline has a presence in India as well as in African, Latin American, and East Asian countries, with registered or under-registration products in Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanmar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, and Venezuela.
Price Band
₹101
Issue Size
₹35.34 Cr
Lot Size
1200 shares
GMP
+2.0%
Est. Listing
₹103
at current GMP
Subscribed
1.34x
overall
Open
26 Sep 2022
Close
29 Sep 2022
Allotment
4 Oct 2022
Refund
5 Oct 2022
Demat Credit
6 Oct 2022
Listing
10 Oct 2022
Designated Registrar: Link Intime India Private Limited
Allotment Date
4 Oct 2022
Basis finalization
Refunds Initiate
5 Oct 2022
Mandate release
Demat Credit
6 Oct 2022
Shares in demat
Listing Debut
10 Oct 2022
Trading begins
Trident Lifeline Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹35.34 Crores. The shares are offered at a price band of ₹101 to ₹101 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1200 shares (approx. ₹1,21,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2022-10-06, while un-allotted funds or UPI block mandates will be released on 2022-10-05.
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.